Sihuan gains as Dongyan Skin Booster's new specifications approved for launch
06/10/2026 03:59
BUZZ-Sihuan gains as Dongyan Skin Booster's new specifications approved for launch ** Shares of Sihuan Pharmaceutical Holdings Group 0460.HK gain 2.8% to HK$0.72, on track for the biggest one-day pct rise since September 21
** Chinese pharmaceutical and aesthetic products developer says five new specifications of the Hyaluronic Acid Sodium Composite Solution for Injection, or Dongyan Skin Booster, have been approved for launch by the National Medical Products Administration of China (NMPA)
** Dongyan is used for injection into dermis layer of the face, effectively improving skin dryness and dullness, covering a wide range of consumer groups -- co
** YTD, stock down 40.7%, while Hang Seng Biotech Index .HSBIO is up 17.6%
(Reporting by Donny Kwok)
Recent news on Sihuan Pharmaceutical Holdings
See all newsBrief: Sihuan Pharma Says Products Developed By Unit Approved For Market Launch In Hong Kong
Brief: Sihuan Pharma's Unit Completes Strategic Equity Investment In Canton Biologics
Sihuan gains as Dongyan Skin Booster's new specifications approved for launch
Brief: Sihuan Pharma Says New Specifications Of Dongyan Skin Booster Approved For Launch By NMPA
Sihuan Pharmaceutical H1 profit jumps on medical aesthetics unit strength